165 related articles for article (PubMed ID: 30788878)
1. Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.
Bates JE; De Leo AN; Morris CG; Amdur RJ; Dagan R
Head Neck; 2019 Jul; 41(7):2309-2314. PubMed ID: 30788878
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience.
Mohamed AA; Goncalves M; Singh BP; Tometten M; Rashad A; Hölzle F; Hackenberg S; Eble M
Strahlenther Onkol; 2024 May; 200(5):400-408. PubMed ID: 38063900
[TBL] [Abstract][Full Text] [Related]
3. Improved overall survival in head and neck cancer patients after specific therapy of distant metastases.
Schulz D; Wirth M; Piontek G; Knopf A; Straube C; Pigorsch S; Combs SE; Pickhard A
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1239-1247. PubMed ID: 29520497
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Bonomo P; Greto D; Desideri I; Loi M; Di Cataldo V; Orlandi E; Iacovelli NA; Becherini C; Visani L; Salvestrini V; Mariotti M; Livi L
Oral Oncol; 2019 Jun; 93():1-7. PubMed ID: 31109688
[TBL] [Abstract][Full Text] [Related]
6. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
Milano MT; Katz AW; Zhang H; Okunieff P
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):878-86. PubMed ID: 22172903
[TBL] [Abstract][Full Text] [Related]
7. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer.
Franzese C; Badalamenti M; Teriaca A; De Virgilio A; Mercante G; Cavina R; Ferrari D; Santoro A; Spriano G; Scorsetti M
J Cancer Res Clin Oncol; 2021 May; 147(5):1307-1313. PubMed ID: 33471186
[TBL] [Abstract][Full Text] [Related]
8. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
[TBL] [Abstract][Full Text] [Related]
9. Curative intent Stereotactic Ablative Radiation Therapy (SABR) for treatment of lung oligometastases from head and neck squamous cell carcinoma (HNSCC): a multi-institutional retrospective study.
Debbi K; Loganadane G; To NH; Kinj R; Husain ZA; Chapet S; Nguyen NP; Barillot I; Benezery K; Belkacemi Y; Calais G
Br J Radiol; 2022 May; 95(1133):20210033. PubMed ID: 35143326
[TBL] [Abstract][Full Text] [Related]
10. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
11. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
[TBL] [Abstract][Full Text] [Related]
12. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
[TBL] [Abstract][Full Text] [Related]
13. Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Sun XS; Michel C; Babin E; De Raucourt D; Péchery A; Gherga E; Géry B; Florescu C; Bourhis J; Thariat J
Future Oncol; 2018 Apr; 14(9):877-889. PubMed ID: 29578359
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome and patterns of failure in patients with advanced head and neck cancer.
Hauswald H; Simon C; Hecht S; Debus J; Lindel K
Radiat Oncol; 2011 Jun; 6():70. PubMed ID: 21663634
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.
Perry DJ; Chan K; Wolden S; Zelefsky MJ; Chiu J; Cohen G; Zaider M; Kraus D; Shah J; Lee N
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1140-6. PubMed ID: 19560882
[TBL] [Abstract][Full Text] [Related]
16. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?
Narayan K; Crane CH; Kleid S; Hughes PG; Peters LJ
Head Neck; 1999 Oct; 21(7):606-13. PubMed ID: 10487947
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of stereotactic radiosurgery for head and neck malignancies.
Owen D; Iqbal F; Pollock BE; Link MJ; Stien K; Garces YI; Brown PD; Foote RL
Head Neck; 2015 Nov; 37(11):1557-62. PubMed ID: 24912475
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
Pasalic D; Betancourt-Cuellar SL; Taku N; Ludmir EB; Lu Y; Allen PK; Tang C; Antonoff MB; Fuller CD; Rosenthal DI; Morrison WH; Phan J; Garden AS; Welsh JW; Chang JY; Liao Z; Erasmus JJ; Nguyen QN
Head Neck; 2020 Aug; 42(8):1939-1953. PubMed ID: 32129548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]